'Troublesome' or not? Ranbaxy recalls US atorvastatin lots but hints at quick resolution
This article was originally published in Scrip
Executive Summary
Shares of Ranbaxy fell by more than 3% on Indian bourses after the company said that it was recalling certain lots of atorvastatin calcium tablets, generic versions of Pfizer's cholesterol lowering drug Lipitor, in the US over concerns about the presence of small glass particles.